
Dr. Jonathan Fellows, DO, board-certified neurologist and director of the Alzheimer’s Disease and Memory Disorder Center at the Michigan Institute for Neurological Disorders (MIND), was recently interviewed by Healio for a Q&A on the future of Alzheimer’s care.
Dr. Fellows noted that access to treatment and early detection remain the greatest challenges, especially as new therapies like Leqembi and Kisunla are most effective in the earliest stages of disease. He also discussed the potential of at-home injectables, which could expand access by easing demand on infusion centers, and highlighted the robust pipeline of new Alzheimer’s treatments under development.
Beyond medications, Dr. Fellows emphasized the role of lifestyle changes—including exercise, cardiovascular health, diet, and social engagement—in helping to delay or slow progression.
Read the full Healio interview: https://www.healio.com/news/neurology/20250925/qa-access-to-care-early-detection-methods-most-pressing-issues-in-alzheimers-disease